Latest filing published 15 Oct 2013 for Traws Pharma, Inc., €22k.
Insider track record
No signal scores available.
James Altland: trading record in brief
All filings by James Altland on record concern Traws Pharma, Inc. Between 30 July 2013 and 10 October 2013, the trades on record add up to 2 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 15 October 2013, the filings show an option exercise worth €22k in Traws Pharma, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to James Altland
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,000 shares@ US$6.00Common StockSEC:0001179110-13-015494:0
- 5,000 shares@ US$6.00Common StockSEC:0001179110-13-012433:0
2 of 2 declarations